Braintree Laboratories

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Braintree Laboratories sits in the top decile of US sponsors by registered trial count (#380 of 15,742 sponsors by registered trial count).

49 total trials none currently recruiting 48 completed later-stage tilt top decile by trial count

Braintree Laboratories: 49 sponsored US clinical trials, none currently recruiting.

Braintree Laboratories sponsors 49 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 48 completed. 33 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Colonoscopy, with 4 trials.

Top-decile sponsor footprint

Braintree Laboratories ranks in the top decile of sponsors by registered trial count (#380 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 85/100

48 of 49 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

49 total, page 1 of 1

COMPLETED Phase 3

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

NCT05890001

COMPLETED Phase 3

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

NCT05587309

COMPLETED Phase 3

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease

NCT05587322

COMPLETED Phase 3

Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

NCT04446299

COMPLETED Phase 3

Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

NCT04446312

COMPLETED Phase 4

An Open-Label Preference Evaluation of BLI800

NCT04214301

COMPLETED Phase 3

A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy

NCT03404401

COMPLETED Phase 2

A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects

NCT03328507

COMPLETED Phase 3

A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

NCT03261960

COMPLETED Phase 2

BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

NCT03103581

COMPLETED Phase 1

A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

NCT03023085

COMPLETED Phase 3

An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults

NCT02819310

COMPLETED Phase 2

A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

NCT02822508

COMPLETED Phase 3

BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

NCT02819297

COMPLETED Phase 3

A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

NCT02819323

COMPLETED Phase 2

A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

NCT02820714

COMPLETED Phase 2

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects

NCT02665728

COMPLETED Phase 2

A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

NCT02604680

COMPLETED Phase 3

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

NCT02481947

COMPLETED Phase 2

A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy

NCT02376465

COMPLETED Phase 2

Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

NCT02189850

COMPLETED Phase 2

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

NCT01815450

COMPLETED Phase 4

BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

NCT01786629

COMPLETED Phase 2

A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults

NCT01687985

COMPLETED Phase 3

A Safety Study of 3 Different Bowel Cleansing Preparations

NCT01501513

TERMINATED Phase 2

A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease

NCT01442363

COMPLETED Phase 2

BLI801 Laxative in Constipated Adults

NCT01301781

COMPLETED Phase 2

BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

NCT01241331

COMPLETED Phase 4

F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

NCT00857272

COMPLETED Phase 3

BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

NCT00856843

COMPLETED Phase 3

BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

NCT00756548

COMPLETED Phase 3

BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

NCT00756977

COMPLETED Phase 2

A Pilot Efficacy Evaluation of BLI-801 as a Laxative in Constipated Adults

NCT00583154

COMPLETED Phase 4

A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

NCT00583609

COMPLETED Phase 1

An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters

NCT00583713

COMPLETED Phase 3

BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

NCT00503607

COMPLETED Phase 3

BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

NCT00503815

COMPLETED Phase 4

A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population

NCT00425594

COMPLETED Phase 3

Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)

NCT00373334

COMPLETED Phase 4

A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children

NCT00319670

COMPLETED Phase 4

An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

NCT00278967

COMPLETED Phase 4

Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.

NCT00164177

COMPLETED Phase 4

Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation

NCT00153140

COMPLETED Phase 4

Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients

NCT00153153

COMPLETED Phase 4

An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients

NCT00164125

COMPLETED Phase 4

PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children

NCT00153114

COMPLETED Phase 4

Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications

NCT00153127

COMPLETED Phase 3

A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.

NCT00164151

COMPLETED Phase 3

HalfLytely Bowel Prep System for Colonoscopy

NCT00164164

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 14
Phase 3 20
Phase 4 13

How the Braintree Laboratories archive is shaped

49 indexed studies, none listed as recruiting (0% open); 48 completed (98%).

Phase mix: 33 late (III/IV) vs 16 early (I/II) (later-stage heavy).

Top condition: Colonoscopy (4 trials), 7 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Braintree Laboratories: archived-pipeline peers nationwide

Peers matched on 49 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Braintree Laboratories sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0204060 0%10%20%30%40%50% Total trials Recruiting share Braintree LaboratoriesAlnylam PharmaceuticalsargenxCynosureMirati Therapeutics10xBio22nd Century Group23andMe3-C Institute for Social Development
Braintree Laboratories sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Braintree Laboratories sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 49 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Braintree Laboratories page

49 registered trials is a research-attention snapshot, not an endorsement of Braintree Laboratories or any single study.

  • None of Braintree Laboratories's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Colonoscopy is the condition Braintree Laboratories studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Colonoscopy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Braintree Laboratories pipeline card: 49 registered trials from official public datasets.Report a data error.